Genomic characterization of respiratory syncytial virus 2022-2023 outbreak in Washington State, USA
Preprint
Abstract
Mitigation measures against the COVID-19 pandemic affected the RSV seasonality and led to an unexpectedly high number of RSV cases in Washington State since October 2022. Here we describe the RSV genomic characteristics and evolutionary relationship of 2022 outbreak compared to the previous RSV outbreaks in the region and globally.Keywords
All Related Versions
- Published version: Emerging Infectious Diseases, 29 (4), 865.
This publication has 9 references indexed in Scilit:
- RSV reemergence in Argentina since the SARS-CoV-2 pandemicJournal of Clinical Virology, 2022
- Respiratory syncytial virus: paying the immunity debt with interestThe Lancet Child & Adolescent Health, 2021
- Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019–Related Public Health MeasuresClinical Infectious Diseases, 2021
- Genetic Diversity and Evolution of Viral Populations2021
- Epidemiology of Respiratory Syncytial Virus Across Five Influenza Seasons Among Adults and Children One Year of Age and Older—Washington State, 2011/2012–2015/2016The Journal of Infectious Diseases, 2020
- Toward unified molecular surveillance of RSV: A proposal for genotype definitionInfluenza and Other Respiratory Viruses, 2020
- IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic EraMolecular Biology and Evolution, 2020
- Rule-Out Outbreak: 24-Hour Metagenomic Next-Generation Sequencing for Characterizing Respiratory Virus Source for Infection PreventionJournal of the Pediatric Infectious Diseases Society, 2017